Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Pharmacological profile of a selective ETA antagonist

June 5, 1998

TA-606, an orally active prodrug of the potent AII antagonist 606A

June 4, 1998

Chinese herbal drug tetramethylpyrazine inhibits ET-1-induced vasoconstriction

June 3, 1998

Nibentan, a potentially safer class III antiarrhythmic agent

June 2, 1998

Cordox enters phase II for treatment of heart transplant patients

June 2, 1998

NHE inhibition with dietary cariporide proves beneficial in infarct model

June 2, 1998

EMD-96785: a promising cardioprotective agent from Merck KGaA

June 2, 1998

Hemodynamic and electrophysiological effects of S-16257 assessed in dogs

June 2, 1998

ECG and hemodynamic evaluation of dronedarone, a new antiarrhythmic agent

June 1, 1998

JTV-519, a novel cardioprotective agent, and propranolol protect myocardium following SAH

June 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...